全文获取类型
收费全文 | 26889篇 |
免费 | 2364篇 |
国内免费 | 964篇 |
专业分类
耳鼻咽喉 | 127篇 |
儿科学 | 517篇 |
妇产科学 | 267篇 |
基础医学 | 8551篇 |
口腔科学 | 402篇 |
临床医学 | 2344篇 |
内科学 | 4675篇 |
皮肤病学 | 872篇 |
神经病学 | 794篇 |
特种医学 | 265篇 |
外国民族医学 | 12篇 |
外科学 | 1573篇 |
综合类 | 3775篇 |
现状与发展 | 5篇 |
预防医学 | 845篇 |
眼科学 | 200篇 |
药学 | 1449篇 |
1篇 | |
中国医学 | 444篇 |
肿瘤学 | 3099篇 |
出版年
2024年 | 29篇 |
2023年 | 243篇 |
2022年 | 389篇 |
2021年 | 662篇 |
2020年 | 590篇 |
2019年 | 652篇 |
2018年 | 648篇 |
2017年 | 682篇 |
2016年 | 769篇 |
2015年 | 1008篇 |
2014年 | 1383篇 |
2013年 | 1696篇 |
2012年 | 1439篇 |
2011年 | 2000篇 |
2010年 | 1700篇 |
2009年 | 1860篇 |
2008年 | 1664篇 |
2007年 | 1647篇 |
2006年 | 1559篇 |
2005年 | 1403篇 |
2004年 | 1257篇 |
2003年 | 1132篇 |
2002年 | 950篇 |
2001年 | 767篇 |
2000年 | 661篇 |
1999年 | 577篇 |
1998年 | 551篇 |
1997年 | 417篇 |
1996年 | 424篇 |
1995年 | 426篇 |
1994年 | 333篇 |
1993年 | 251篇 |
1992年 | 137篇 |
1991年 | 130篇 |
1990年 | 64篇 |
1989年 | 39篇 |
1988年 | 20篇 |
1987年 | 9篇 |
1986年 | 5篇 |
1985年 | 7篇 |
1984年 | 12篇 |
1983年 | 5篇 |
1982年 | 5篇 |
1981年 | 8篇 |
1979年 | 3篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1973年 | 1篇 |
1906年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
CA19-9及其同分异构体CD15s在大肠癌表达的对比研究 总被引:5,自引:0,他引:5
目的:探讨CA19-9及其同分异构体CD15s在大肠癌中的表达及其与肿瘤发生、分化、转移及预后的关系.方法:应用催化信号放大法(CSA)检测150例大肠癌、84例转移淋巴结和50例远离癌组织的正常大肠黏膜CA19-9及其同分异构体CD15s的表达状况.结果:CA19-9和CD15s阳性物质在远离癌组织的正常大肠黏膜中阳性表达率分别为88.0%(44/50)和18.0%(9/50),在大肠癌组织中阳性率分别为81.3%(122/150)和94.0%(141/150),转移淋巴结标本中阳性率分别为66.7%(56/84)和95.2%(80/84).结论:作为预测大肠癌侵袭、转移及评估患者预后的肿瘤相关抗原,CD15s比CA19-9具有更重要的临床意义. 相似文献
102.
Following Anti-CD25 Treatment, A Functional CD4+CD25+ Regulatory T-Cell Pool Is Present in Renal Transplant Recipients 总被引:4,自引:0,他引:4
E. Kreijveld H. J. P. M. Koenen I. S. Klasen L. B. Hilbrands I. Joosten 《American journal of transplantation》2007,7(1):249-255
Daclizumab, a humanized antibody directed against the alpha-chain of the interleukin-2 receptor (CD25), has shown efficacy in the prevention of acute rejection following organ transplantation. However, anti-CD25 therapy can be expected to affect not only alloreactive effector T cells, but also CD4(+)CD25(+) regulatory T (Treg) cells that are shown to play an important role in the induction of transplantation tolerance. Therefore, the size and function of the Treg pool in human renal allograft recipients after single-dose daclizumab administration was investigated in this study. Approximately 8 weeks after administration, daclizumab was cleared from the circulation and the Treg population then present appeared not different from that observed before transplantation. Functional analysis revealed that the Treg possessed a normal capacity to suppress mixed lymphocyte reactions in vitro. These data indicate that after daclizumab therapy a Treg population, normal in number and function, is present in the peripheral blood of renal transplant recipients. 相似文献
103.
目的 探讨Fas/Apo-1(CD95)在下肢静脉性溃疡的表达及意义.方法 采用流式细胞技术、半定量逆转录-聚合酶链反应(RT-PCR)和免疫组织化学方法检测不同体位下肢外周血和局部皮肤Fas/Apo-l(CD95)的表达.结果 溃疡组平卧位、下垂位血液中Fas/Apo-1(CD95)阳性细胞数分别为41.45±14.25、40.20±12.42,mRNA为0.74±0.33、0.78±0.22,皮肤中阳性细胞数为42.62±22.19、46.50±20.12,分别与无溃疡组和对照组比较,差异均有统计学意义(P<0.05);无溃疡组和对照组比较,差异无统计学意义(P>0.05);不同体位之间Fas/Apo-1(CD95)阳性细胞数和含量比较,差异无统计学意义(P>0.05).结论 Fas/Apo-1高表达可能与下肢静脉性溃疡发生密切相关. 相似文献
104.
目的探讨弥漫性大B细胞淋巴瘤(DLBCL)组织中CD40L表达与DLBCL预后间的关系及意义。方法免疫组织化学法检测27例弥漫性大B细胞淋巴瘤、20例淋巴结反应性增生组织中CD40L的表达。结果(1)DLBCL中CD40L过度阳性率(25.93%)显著低于淋巴结反应性增生(63.64%),P〈0.05。(2)CD40L在Ⅲ、Ⅳ期DLBCL过度阳性率(14.29%)低于Ⅰ、Ⅱ期(38.46%),P〈0.05。CD40L过度阳性率在有结外浸润DLBCL(11.76%)低于无有结外浸润DLBCL(40%),P〈0.05。(3)DLBCL患者CD40L的过度阳性率与远处转移、临床分期均显著相关,P〈0.05。结论(1)CD40L过度阳性率与结外器官浸润及临床分期密切相关,其可能作为判断DLBCL侵袭性及预后的指标。(2)DLBCL中CD40L表达的减少可能是影响其发病的因素之一。 相似文献
105.
CD44v6和组织蛋白酶D表达与食管癌预后的关系 总被引:2,自引:0,他引:2
目的 研究CD4 4v6和组织蛋白酶D(cathepsinD ,CD)表达与食管癌生物学行为的关系。方法 应用免疫组化法 ,检测 6 5例食管鳞状细胞癌组织中CD4 4v6和CD表达水平。结果 在食管癌中CD4 4v6和CD表达阳性率分别为 5 8.5 %和 6 4 .6 %。CD4 4v6和CD表达均与肿瘤分级、浸润、淋巴结转移和预后相关。结论 CD4 4v6和CD异常表达与食管癌的病理生物学行为密切相关 ,可作为是预测食管癌转移潜能和评估食管癌预后的客观指标 相似文献
106.
Fotios A. Asimakopoulos Nicholas J. White Elisabeth P. Nacheva & Anthony R. Green 《British journal of haematology》1995,92(1):127-130
Deletions of chromosome 20q are associated with myeloid malignancies and have been previously shown to arise in a multipotent progenitor of both myeloid and B cells. However, B-cell differentiation from the abnormal progenitor was impaired. The CD40 antigen is a surface glycoprotein which is expressed in B cells and haemopoietic stem cells and is important for B-cell growth and development. Following the recent mapping of CD40 to chromosome 20q we sought to determine its position relative to 20q deletions. Analysis of lymphoblastoid cell lines carrying 20q deletions placed CD40 within a 19–21 cM interval which is almost coincidental with the common deleted region defined by previous analysis of patient samples. Our results raise the possibility that genetic alteration of this locus may contribute to the pathogenesis of myeloid disorders associated with 20q deletions. 相似文献
107.
CD24 expression on human keratinocytes 总被引:4,自引:0,他引:4
Pedro Redondo Jesús García-Foncillas Iouri Okroujnov Iñigo de Felipe Emilio Quintanilla 《Experimental dermatology》1998,7(4):175-178
Abstract: CD24 or Nectadrin is a cell surface glycoprotein expressed in pre-B lymphocytes, T lymphocytes, neurons, muscle cells and carcinoma cells. Its function is not completely known, but it has been suggested that it is involved in cell adhesion and signalling. CD24 has recently been identified as the human molecule homologous to the murine heat-stable antigen (HSA). HSA is expressed by murine keratinocytes and delivers costimulatory signals in T-cell activation. Long-term cultures of normal human keratinocytes (HKC) were obtained from skin of human female breast sections and either left untreated or were treated with phorbol-12-myristate-13-acetate (PMA) at 10–100 ng/ml, calcium 0.5–2 mM or IFN-γ 100–1000 U/ml, for 24–48 h. Using RT-PCR and flow cytometry we showed that HKC express low levels of CD24 even under basal conditions, and the treatment with calcium, PMA or IFN-γ increased levels of CD24 mRNA and protein. To the best of our knowledge, this is the first report to measure CD24 expression and production by cultured HKC in basal conditions and after stimulation. Further studies are needed to determine biological and therapeutical relevance of these findings. 相似文献
108.
109.
F. DE ARRIBA M. L. LOZANO F. ORTUÑO I. HERAS J. M. MORALEDA & V. VICENTE 《British journal of haematology》1997,96(2):418-420
Thirty patients diagnosed with breast cancer were included in a prospective randomized study comparing the in vivo priming effect of bioequivalent doses of glycosylated (lenograstim) and nonglycosylated (filgrastim) rG-CSF administration. Analysis of the efficacy of equivalent biological doses of both rG-CSFs showed no significant differences either in the mobilization of the subpopulations of PBPC considered (CD34+ , CD34+ /38− , CD34+ /DR− ), the content of such CD34+ cell subsets in the leukapheresis product, or the cost of the mobilization and collection procedures between both recombinant molecules. These results suggest that priming with bioequivalent doses of the two commercially available forms of glycosylated or nonglycosylated rG-CSF has a similar in vivo effect on PBPC mobilization. 相似文献
110.
Sherilyn Gross Karen Helm Jennifer J. Gruntmeir Wayne S. Stillman David W. Pyatt Richard D. Irons 《European journal of haematology》1997,59(5):318-326
Abstract: Our current understanding of human haematopoietic stem cell biology is based in part on the characterization of human CD34+ bone marrow cell differentiation in vitro. CD34 is highly expressed on early stem cells and haematopoietic progenitor cells with clonogenic potential and is gradually lost during differentiation and commitment. However, CD71 (transferrin receptor) is expressed at low levels on early stem cells and generally increases during haematopoietic progenitor cell proliferation. We reasoned that the combination of these surface markers would provide a useful framework for the simultaneous analysis of multiple lineage differentiation of CD34+ haematopoietic progenitor cells in liquid culture. In this report, we identify the phenotype of distinct subpopulations of myeloid, erythroid and lymphoid cells in liquid suspension culture using differential expression of CD34 vs. CD71 in combination with specific lineage markers. Freshly isolated human CD34+ bone marrow cells were introduced into suspension culture and monitored over a 6-d period using 3-colour flow cytometry. This is the first demonstration that differential expression of CD34 vs. CD71 can be used to simultaneously monitor differentiation of multiple haematopoietic cell lineages in liquid suspension culture, facilitating the study of cytokine-, drug- or chemical-induced alterations in haematopoietic progenitor cell differentiation in vitro. 相似文献